| Clinical data | |
|---|---|
| Other names | Thiamylal, Thioseconal, Surital |
| AHFS/Drugs.com | International Drug Names |
| ATCvet code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Eliminationhalf-life | 14.3 h (cats) |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| IUPHAR/BPS | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.000.927 |
| Chemical and physical data | |
| Formula | C12H18N2O2S |
| Molar mass | 254.35 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Thiamylal (Surital) is abarbiturate derivative invented in the 1950s. It hassedative,anticonvulsant, andhypnotic effects, and is used as a strong but short acting sedative. Thiamylal is still in current use, primarily for induction insurgicalanaesthesia[2] or as an anticonvulsant to counteract side effects from other anaesthetics.[3] It is the thiobarbiturate analogue ofsecobarbital.